These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11053095)

  • 1. Arguments for interleukin 1 as a target in chronic arthritis.
    van den Berg WB
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i81-4. PubMed ID: 11053095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cytokine therapy in chronic destructive arthritis.
    van den Berg WB
    Arthritis Res; 2001; 3(1):18-26. PubMed ID: 11178124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a rationale for combined TNF and IL-1 blocking in arthritis?
    van den Berg WB
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S21-5. PubMed ID: 14989425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint inflammation and cartilage destruction may occur uncoupled.
    van den Berg WB
    Springer Semin Immunopathol; 1998; 20(1-2):149-64. PubMed ID: 9836374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling of inflammatory and destructive mechanisms in arthritis.
    van den Berg WB
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):7-16. PubMed ID: 11357166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation.
    Hayer S; Bauer G; Willburger M; Sinn K; Alasti F; Plasenzotti R; Shvets T; Niederreiter B; Aschauer C; Steiner G; Podesser BK; Smolen JS; Redlich K
    Dis Model Mech; 2016 Nov; 9(11):1329-1338. PubMed ID: 27638666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
    Goldring SR
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 is essential for systemic inflammatory bone loss.
    Polzer K; Joosten L; Gasser J; Distler JH; Ruiz G; Baum W; Redlich K; Bobacz K; Smolen JS; van den Berg W; Schett G; Zwerina J
    Ann Rheum Dis; 2010 Jan; 69(1):284-90. PubMed ID: 19196726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I.
    van den Berg WB; Bresnihan B
    Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):577-97. PubMed ID: 10652641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.
    Kuiper S; Joosten LA; Bendele AM; Edwards CK; Arntz OJ; Helsen MM; Van de Loo FA; Van den Berg WB
    Cytokine; 1998 Sep; 10(9):690-702. PubMed ID: 9770330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
    O' Gradaigh D; Ireland D; Bord S; Compston JE
    Ann Rheum Dis; 2004 Apr; 63(4):354-9. PubMed ID: 15020327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction.
    van den Berg WB; Joosten LA; Kollias G; van De Loo FA
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I40-8. PubMed ID: 10577972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
    Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
    Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.